{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:52:25Z","timestamp":1784285545473,"version":"3.55.0"},"reference-count":101,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL134779"],"award-info":[{"award-number":["HL134779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES033345"],"award-info":[{"award-number":["ES033345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epidemiological studies show a strong association between environmental exposure to perfluorooctane sulfonic acid (PFOS) and preeclampsia and fetal growth restriction; however, the underlying mechanisms are unclear. We tested the hypothesis that gestational PFOS exposure leads to pregnancy complications via alterations in uterine vascular endothelium-independent angiotensin II-related mechanisms and endothelium-derived factors such as nitric oxide. Pregnant Sprague-Dawley rats were exposed to PFOS 0.005, 0.05, 0.5, 5, 10, and 50\u00a0\u03bcg\/mL through drinking water from gestational day 4 to 20, and dams with PFOS 50\u00a0\u03bcg\/mL were used to assess mechanisms. PFOS exposure dose dependently increased maternal blood pressure but decreased fetal weights. Uterine artery blood flow was lower and resistance index was higher in the PFOS dams. In PFOS dams, uterine artery contractile responses to angiotensin II were significantly greater, whereas contractile responses to K+ depolarization and phenylephrine were unaffected. Plasma angiotensin II levels were not significantly different between control and PFOS dams; however, PFOS exposure significantly increased Angiotensin II type 1 receptor (AGTR1) and decreased AGTR2 protein levels in uterine arteries. Endothelium-dependent relaxation response to acetylcholine was significantly reduced with decreased endothelial nitric oxide synthase expression in the uterine arteries of PFOS dams. Left ventricular hypertrophy and fibrosis were observed, along with increased ejection fraction and fractional shortening in PFOS dams. These results suggest that elevated maternal PFOS levels decrease uterine blood flow and increase vascular resistance via heightened angiotensin II-mediated vasoconstriction and impaired endothelium-dependent vasodilation, which provides a molecular mechanism linking elevated maternal PFOS levels with gestational hypertension and fetal growth restriction.<\/jats:p>","DOI":"10.1093\/biolre\/ioac141","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T01:36:18Z","timestamp":1657848978000},"source":"Crossref","is-referenced-by-count":10,"title":["Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in the uterine arteries"],"prefix":"10.1093","author":[{"given":"Sri Vidya","family":"Dangudubiyyam","sequence":"first","affiliation":[{"name":"Department of Comparative Biosciences , School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA"},{"name":"Endocrinology\u2013Reproductive Physiology Program , University of Wisconsin, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences , School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences , School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences , School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA"},{"name":"Endocrinology\u2013Reproductive Physiology Program , University of Wisconsin, Madison, WI, USA"},{"name":"Department of Obstetrics and Gynecology , School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"2022081505272622100_ref1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/CIRCULATIONAHA.114.009029","article-title":"Cardiovascular physiology of pregnancy","volume":"130","author":"Sanghavi","year":"2014","journal-title":"Circulation"},{"key":"2022081505272622100_ref2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000301658","article-title":"Circulatory changes in the reproductive tissues of ewes during pregnancy","volume":"5","author":"Rosenfeld","year":"1974","journal-title":"Gynecol Invest"},{"key":"2022081505272622100_ref3","first-page":"58","article-title":"Maternal uterine vascular remodeling during pregnancy","volume":"24","author":"Osol","year":"2009","journal-title":"Physiology (Bethesda)"},{"key":"2022081505272622100_ref4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168622","article-title":"Uteroplacental circulation in normal pregnancy and preeclampsia: functional adaptation and maladaptation","volume":"22","author":"Hu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2022081505272622100_ref5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/FJC.0000000000000468","article-title":"Mechanisms of uterine artery dysfunction in pregnancy complications","volume":"69","author":"Morton","year":"2017","journal-title":"J Cardiovasc Pharmacol"},{"key":"2022081505272622100_ref6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra0708473","article-title":"Effect of in utero and early-life conditions on adult health and disease","volume":"359","author":"Gluckman","year":"2008","journal-title":"N Engl J Med"},{"key":"2022081505272622100_ref7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00003081-200606000-00008","article-title":"Perinatal outcome and later implications of intrauterine growth restriction","volume":"49","author":"Pallotto","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"2022081505272622100_ref8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0140-6736(93)91224-A","article-title":"Fetal nutrition and cardiovascular disease in adult life","volume":"341","author":"Barker","year":"1993","journal-title":"Lancet"},{"key":"2022081505272622100_ref9","doi-asserted-by":"crossref","first-page":"R867","DOI":"10.1152\/ajpregu.00072.2018","article-title":"Fetal undernutrition, placental insufficiency, and pancreatic \u03b2-cell development programming in utero","volume":"315","author":"Mohan","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2022081505272622100_ref10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/beem.2002.0195","article-title":"Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults","volume":"16","author":"Ong","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2022081505272622100_ref11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpobgyn.2009.05.003","article-title":"Aetiology and pathogenesis of IUGR","volume":"23","author":"Sankaran","year":"2009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2022081505272622100_ref12","first-page":"165","article-title":"Predictive factors for intrauterine growth restriction","volume":"7","author":"Albu","year":"2014","journal-title":"J Med Life"},{"key":"2022081505272622100_ref13","first-page":"1384","article-title":"Intrauterine growth retardation","volume":"58","author":"Vandenbosche","year":"1998","journal-title":"Am Fam Physician"},{"key":"2022081505272622100_ref14","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/AOG.0000000000004449","article-title":"Reducing prenatal exposure to toxic environmental agents: ACOG Committee opinion, number 832","volume":"138","author":"Practice ACoOaGCoO","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2022081505272622100_ref15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/aje\/kwx332","article-title":"Early-pregnancy plasma concentrations of perfluoroalkyl substances and birth outcomes in project viva: confounded by pregnancy Hemodynamics?","volume":"187","author":"Sagiv","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2022081505272622100_ref16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.scitotenv.2017.06.273","article-title":"The impact of prenatal perfluoroalkyl substances exposure on neonatal and child growth","volume":"607\u2013608","author":"Chen","year":"2017","journal-title":"Sci Total Environ"},{"key":"2022081505272622100_ref17","doi-asserted-by":"crossref","first-page":"067016","DOI":"10.1289\/EHP641","article-title":"Perfluoroalkyl substances during pregnancy and offspring weight and adiposity at birth: examining mediation by maternal fasting glucose in the healthy start study","volume":"125","author":"Starling","year":"2017","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref18","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1289\/ehp.1003096","article-title":"Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls","volume":"120","author":"Maisonet","year":"2012","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref19","doi-asserted-by":"crossref","first-page":"e42474","DOI":"10.1371\/journal.pone.0042474","article-title":"Perfluorinated compounds in umbilical cord blood and adverse birth outcomes","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"2022081505272622100_ref20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1289\/ehp.1104034","article-title":"Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study","volume":"120","author":"Halldorsson","year":"2012","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref21","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/aje\/kwq289","article-title":"Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy","volume":"172","author":"Andersen","year":"2010","journal-title":"Am J Epidemiol"},{"key":"2022081505272622100_ref22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1289\/ehp.11681","article-title":"Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth","volume":"117","author":"Washino","year":"2009","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1289\/ehp.10334","article-title":"Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth","volume":"115","author":"Apelberg","year":"2007","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref24","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1039\/D0EM00291G","article-title":"An overview of the uses of per- and polyfluoroalkyl substances (PFAS)","volume":"22","author":"Gl\u00fcge","year":"2020","journal-title":"Environ Sci Process Impacts"},{"key":"2022081505272622100_ref25","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/acs.est.6b04806","article-title":"A never-ending story of per- and Polyfluoroalkyl substances (PFASs)?","volume":"51","author":"Wang","year":"2017","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref26","doi-asserted-by":"crossref","first-page":"127900","DOI":"10.1016\/j.chemosphere.2020.127900","article-title":"Assessment of PFAS fate, transport, and treatment inhibition associated with a simulated AFFF release within a WASTEWATER treatment plant","volume":"262","author":"Gonzalez","year":"2021","journal-title":"Chemosphere"},{"key":"2022081505272622100_ref27","doi-asserted-by":"crossref","DOI":"10.3390\/toxics10020044","article-title":"PFAS molecules: a major concern for the human health and the environment","volume":"10","author":"Panieri","year":"2022","journal-title":"Toxics"},{"key":"2022081505272622100_ref28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.reprotox.2011.07.002","article-title":"Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys","volume":"33","author":"Chang","year":"2012","journal-title":"Reprod Toxicol"},{"key":"2022081505272622100_ref29","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1021\/es505399w","article-title":"Isomer-specific binding affinity of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) to serum proteins","volume":"49","author":"Beesoon","year":"2015","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2012.01.003","article-title":"Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats","volume":"293","author":"Butenhoff","year":"2012","journal-title":"Toxicology"},{"key":"2022081505272622100_ref31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.etap.2007.04.003","article-title":"Biliary excretion and cerebrospinal fluid partition of perfluorooctanoate and perfluorooctane sulfonate in humans","volume":"24","author":"Harada","year":"2007","journal-title":"Environ Toxicol Pharmacol"},{"key":"2022081505272622100_ref32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2011.03.014","article-title":"Tissue distribution of (3)(5)S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose","volume":"284","author":"Bogdanska","year":"2011","journal-title":"Toxicology"},{"key":"2022081505272622100_ref33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.envint.2017.06.007","article-title":"Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community","volume":"106","author":"Worley","year":"2017","journal-title":"Environ Int"},{"key":"2022081505272622100_ref34","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref35","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1021\/acs.est.7b00268","article-title":"Isomer-specific Transplacental transfer of perfluoroalkyl acids: results from a survey of paired maternal, cord sera, and placentas","volume":"51","author":"Chen","year":"2017","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref36","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1289\/ehp.6864","article-title":"Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy","volume":"112","author":"Inoue","year":"2004","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref37","doi-asserted-by":"crossref","first-page":"105789","DOI":"10.1016\/j.envint.2020.105789","article-title":"Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study","volume":"141","author":"Borghese","year":"2020","journal-title":"Environ Int"},{"key":"2022081505272622100_ref38","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1038\/s41598-019-45483-7","article-title":"Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women","volume":"9","author":"Wikstrom","year":"2019","journal-title":"Sci Rep"},{"key":"2022081505272622100_ref39","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/aje\/kwt432","article-title":"Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study","volume":"179","author":"Starling","year":"2014","journal-title":"Am J Epidemiol"},{"key":"2022081505272622100_ref40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.envint.2013.10.004","article-title":"Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study","volume":"62","author":"Starling","year":"2014","journal-title":"Environ Int"},{"key":"2022081505272622100_ref41","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1289\/ehp.1206372","article-title":"Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the Mid-Ohio Valley, 2005-2010","volume":"121","author":"Darrow","year":"2013","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/aje\/kwp212","article-title":"Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome","volume":"170","author":"Stein","year":"2009","journal-title":"Am J Epidemiol"},{"key":"2022081505272622100_ref43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12940-018-0445-3","article-title":"Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy","volume":"18","author":"Huang","year":"2019","journal-title":"Environ Health"},{"key":"2022081505272622100_ref44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2605.2008.00870.x","article-title":"Emerging endocrine disrupters: perfluoroalkylated substances","volume":"31","author":"Jensen","year":"2008","journal-title":"Int J Androl"},{"key":"2022081505272622100_ref45","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/es020955c","article-title":"Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals","volume":"37","author":"Olsen","year":"2003","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref46","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1021\/es4057467","article-title":"Highly elevated serum concentrations of perfluoroalkyl substances in fishery employees from Tangxun lake, China","volume":"48","author":"Zhou","year":"2014","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref47","doi-asserted-by":"crossref","first-page":"146A","DOI":"10.1021\/es022253t","article-title":"Perfluorochemical surfactants in the environment","volume":"36","author":"Giesy","year":"2002","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref48","doi-asserted-by":"crossref","DOI":"10.3390\/toxics8020043","article-title":"Per- and polyfluoroalkyl substances in early pregnancy and risk for preeclampsia: a case-control study in southern Sweden","volume":"8","author":"Rylander","year":"2020","journal-title":"Toxics"},{"key":"2022081505272622100_ref49","doi-asserted-by":"crossref","first-page":"106442","DOI":"10.1016\/j.envint.2021.106442","article-title":"Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense Child Cohort","volume":"151","author":"Birukov","year":"2021","journal-title":"Environ Int"},{"key":"2022081505272622100_ref50","doi-asserted-by":"crossref","first-page":"e095","DOI":"10.1097\/EE9.0000000000000095","article-title":"Birth weight and perfluorooctane sulfonic acid: a random-effects meta-regression analysis","volume":"4","author":"Dzierlenga","year":"2020","journal-title":"Environ Epidemiol"},{"key":"2022081505272622100_ref51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.reprotox.2020.09.008","article-title":"Perfluorooctane sulfonic acid (PFOS) exposure during pregnancy increases blood pressure and impairs vascular relaxation mechanisms in the adult offspring","volume":"98","author":"Dangudubiyyam","year":"2020","journal-title":"Reprod Toxicol"},{"key":"2022081505272622100_ref52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kft248","article-title":"Elevated blood pressure in offspring of rats exposed to diverse chemicals during pregnancy","volume":"137","author":"Rogers","year":"2014","journal-title":"Toxicol Sci"},{"key":"2022081505272622100_ref53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tox.2005.07.019","article-title":"Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters","volume":"215","author":"Luebker","year":"2005","journal-title":"Toxicology"},{"key":"2022081505272622100_ref54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tox.2005.07.018","article-title":"Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats","volume":"215","author":"Luebker","year":"2005","journal-title":"Toxicology"},{"key":"2022081505272622100_ref55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/toxsci\/kfg121","article-title":"Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations","volume":"74","author":"Thibodeaux","year":"2003","journal-title":"Toxicol Sci"},{"key":"2022081505272622100_ref56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/toxsci\/kfg122","article-title":"Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation","volume":"74","author":"Lau","year":"2003","journal-title":"Toxicol Sci"},{"key":"2022081505272622100_ref57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.placenta.2016.01.010","article-title":"In utero perfluorooctane sulfonate exposure causes low body weights of fetal rats: a mechanism study","volume":"39","author":"Li","year":"2016","journal-title":"Placenta"},{"key":"2022081505272622100_ref58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2131\/jts.33.219","article-title":"Neonatal death of mice treated with perfluorooctane sulfonate","volume":"33","author":"Yahia","year":"2008","journal-title":"J Toxicol Sci"},{"key":"2022081505272622100_ref59","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/toxsci\/kfj105","article-title":"Effects of perfluorooctanoic acid exposure during pregnancy in the mouse","volume":"90","author":"Lau","year":"2006","journal-title":"Toxicol Sci"},{"key":"2022081505272622100_ref60","year":"2020"},{"key":"2022081505272622100_ref61","volume-title":"Health Effects Support Document for Perfluorooctane Sulfonate (PFOS). EPA 822-R-16-002","author":"EPA"},{"key":"2022081505272622100_ref62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/ijerph10020699","article-title":"Placental transfer of persistent organic pollutants: a preliminary study on mother-newborn pairs","volume":"10","author":"Porpora","year":"2013","journal-title":"Int J Environ Res Public Health"},{"key":"2022081505272622100_ref63","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/15287391003689317","article-title":"Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability","volume":"73","author":"Qian","year":"2010","journal-title":"J Toxicol Environ Health A"},{"key":"2022081505272622100_ref64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbrc.2011.05.128","article-title":"Perfluorooctane sulfonate triggers tight junction \"opening\" in brain endothelial cells via phosphatidylinositol 3-kinase","volume":"410","author":"Wang","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"2022081505272622100_ref65","doi-asserted-by":"crossref","first-page":"118543","DOI":"10.1016\/j.envpol.2021.118543","article-title":"Perfluorooctane sulfonic acid (PFOS) inhibits vessel formation in a human 3D co-culture angiogenesis model (NCFs\/HUVECs)","volume":"293","author":"Forsthuber","year":"2022","journal-title":"Environ Pollut"},{"key":"2022081505272622100_ref66","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1289\/ehp.1103412","article-title":"Environmental impact on vascular development predicted by high-throughput screening","volume":"119","author":"Kleinstreuer","year":"2011","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref67","doi-asserted-by":"crossref","first-page":"113429","DOI":"10.1016\/j.envpol.2019.113429","article-title":"Perfluorooctane sulfonate disrupts the blood brain barrier through the crosstalk between endothelial cells and astrocytes in mice","volume":"256","author":"Yu","year":"2020","journal-title":"Environ Pollut"},{"key":"2022081505272622100_ref68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3892\/etm.2021.10936","article-title":"Perfluorooctane sulfonate induces heart toxicity involving cardiac apoptosis and inflammation in rats","volume":"23","author":"Xu","year":"2021","journal-title":"Exp Ther Med"},{"key":"2022081505272622100_ref69","doi-asserted-by":"crossref","first-page":"106567","DOI":"10.1016\/j.envint.2021.106567","article-title":"Gestational exposure to perfluoroalkyl substances and congenital heart defects: a nested case-control pilot study","volume":"154","author":"Ou","year":"2021","journal-title":"Environ Int"},{"key":"2022081505272622100_ref70","volume-title":"Drinking Water Health Advisory for Perfluorooctane Sulfonate (PFOS). Office of Water document 822-R-16-004; U.S","author":"EPA US","year":"2016"},{"key":"2022081505272622100_ref71","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1017\/S0007114511003448","article-title":"Protein restriction during pregnancy induces hypertension in adult female rat offspring--influence of oestradiol","volume":"107","author":"Sathishkumar","year":"2012","journal-title":"Br J Nutr"},{"key":"2022081505272622100_ref72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-7030-8_6","article-title":"Measuring blood pressure using a noninvasive tail cuff method in mice","volume":"1614","author":"Wang","year":"2017","journal-title":"Methods Mol Biol"},{"key":"2022081505272622100_ref73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.115.06946","article-title":"Elevated testosterone reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant rats","volume":"67","author":"Gopalakrishnan","year":"2016","journal-title":"Hypertension"},{"key":"2022081505272622100_ref74","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/1933719116673199","article-title":"Postnatal cardiovascular consequences in the offspring of pregnant rats exposed to smoking and smoking cessation pharmacotherapies","volume":"24","author":"Gopalakrishnan","year":"2017","journal-title":"Reprod Sci"},{"key":"2022081505272622100_ref75","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-\u03b2","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J Clin Invest"},{"key":"2022081505272622100_ref76","article-title":"Epigenetics in the uterine environment: how maternal diet and ART may influence the epigenome in the offspring with long-term health consequences","volume":"13","author":"Peral-Sanchez","year":"2022","journal-title":"Genes (Basel)"},{"key":"2022081505272622100_ref77","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.envint.2019.01.010","article-title":"Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies","volume":"124","author":"Mamsen","year":"2019","journal-title":"Environ Int"},{"key":"2022081505272622100_ref78","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/acs.est.6b06049","article-title":"Chlorinated Polyfluoroalkyl ether sulfonic acids in matched maternal, cord, and placenta samples: a study of Transplacental transfer","volume":"51","author":"Chen","year":"2017","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.envint.2015.07.014","article-title":"Perfluoroalkyl acid (PFAA) levels and profiles in breast milk, maternal and cord serum of French women and their newborns","volume":"84","author":"Cariou","year":"2015","journal-title":"Environ Int"},{"key":"2022081505272622100_ref80","doi-asserted-by":"crossref","first-page":"9600","DOI":"10.1021\/es501811k","article-title":"Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003\u20132006","volume":"48","author":"Kato","year":"2014","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref81","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1021\/es400937y","article-title":"Distribution of poly- and perfluoroalkyl substances in matched samples from pregnant women and carbon chain length related maternal transfer","volume":"47","author":"Zhang","year":"2013","journal-title":"Environ Sci Technol"},{"key":"2022081505272622100_ref82","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.chemosphere.2012.08.035","article-title":"Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea","volume":"90","author":"Lee","year":"2013","journal-title":"Chemosphere"},{"key":"2022081505272622100_ref83","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijheh.2011.08.011","article-title":"Placental transfer of perfluorinated compounds is selective--a Norwegian Mother and Child sub-cohort study","volume":"215","author":"Gutzkow","year":"2012","journal-title":"Int J Hyg Environ Health"},{"key":"2022081505272622100_ref84","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1289\/ehp.1003265","article-title":"Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer","volume":"119","author":"Beesoon","year":"2011","journal-title":"Environ Health Perspect"},{"key":"2022081505272622100_ref85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-9378(90)90834-T","article-title":"Changes in uterine blood flow during human pregnancy","volume":"162","author":"Thaler","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"2022081505272622100_ref86","doi-asserted-by":"crossref","first-page":"R906","DOI":"10.1152\/ajpregu.00164.2008","article-title":"Lower uterine artery blood flow and higher endothelin relative to nitric oxide metabolite levels are associated with reductions in birth weight at high altitude","volume":"295","author":"Julian","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2022081505272622100_ref87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1152\/jappl.1995.79.1.15","article-title":"Alterations in uteroplacental blood flow precede hypertension in preeclampsia at high altitude","volume":"79","author":"Zamudio","year":"1995","journal-title":"J Appl Physiol (1985)"},{"key":"2022081505272622100_ref88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/clc.4960181507","article-title":"Angiotensin receptors: physiology and pharmacology","volume":"18","author":"Guthrie","year":"1995","journal-title":"Clin Cardiol"},{"key":"2022081505272622100_ref89","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/biolre\/ioy130","article-title":"Pregnancy upregulates angiotensin type 2 receptor expression and increases blood flow in uterine arteries of rats","volume":"99","author":"Mishra","year":"2018","journal-title":"Biol Reprod"},{"key":"2022081505272622100_ref90","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"2022081505272622100_ref91","first-page":"R441","article-title":"Nitric oxide and pregnancy","volume":"272","author":"Sladek","year":"1997","journal-title":"Am J Physiol"},{"key":"2022081505272622100_ref92","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1095\/biolreprod64.4.1033","article-title":"Angiogenesis in the placenta","volume":"64","author":"Reynolds","year":"2001","journal-title":"Biol Reprod"},{"key":"2022081505272622100_ref93","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/beog.2000.0139","article-title":"Angiogenesis and intrauterine growth restriction","volume":"14","author":"Ahmed","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"2022081505272622100_ref94","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.placenta.2011.08.008","article-title":"Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast","volume":"32","author":"Groesch","year":"2011","journal-title":"Placenta"},{"key":"2022081505272622100_ref95","doi-asserted-by":"crossref","first-page":"104988","DOI":"10.1016\/j.tiv.2020.104988","article-title":"Perfluorooctane sulfonate induced toxicity in embryonic stem cell-derived cardiomyocytes via inhibiting autophagy-lysosome pathway","volume":"69","author":"Liu","year":"2020","journal-title":"Toxicol In Vitro"},{"key":"2022081505272622100_ref96","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tox.2017.03.011","article-title":"Mitochondrial toxicity of perfluorooctane sulfonate in mouse embryonic stem cell-derived cardiomyocytes","volume":"382","author":"Tang","year":"2017","journal-title":"Toxicology"},{"key":"2022081505272622100_ref97","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1748-1716.2010.02234.x","article-title":"Pregnancy protects against antiangiogenic and fibrogenic effects of angiotensin II in rat hearts","volume":"201","author":"Aljabri","year":"2011","journal-title":"Acta Physiol (Oxf)"},{"key":"2022081505272622100_ref98","doi-asserted-by":"crossref","first-page":"103434","DOI":"10.1016\/j.etap.2020.103434","article-title":"Combined effects of BPA and PFOS on fetal cardiac development: in vitro and in vivo experiments","volume":"80","author":"Zhou","year":"2020","journal-title":"Environ Toxicol Pharmacol"},{"key":"2022081505272622100_ref99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/9780470942390.mo100130","article-title":"Echocardiography in mice","volume":"1","author":"Gao","year":"2011","journal-title":"Curr Protoc Mouse Biol"},{"key":"2022081505272622100_ref100","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2019.02.008","article-title":"TNF-alpha inhibits pregnancy-adapted Ca(2+) signaling in uterine artery endothelial cells","volume":"488","author":"Ampey","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"2022081505272622100_ref101","doi-asserted-by":"crossref","first-page":"e73731","DOI":"10.1371\/journal.pone.0073731","article-title":"Chronic hypoxia during gestation enhances uterine arterial myogenic tone via heightened oxidative stress","volume":"8","author":"Xiao","year":"2013","journal-title":"PLoS One"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioac141\/45417050\/ioac141.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioac141\/45417050\/ioac141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T15:53:43Z","timestamp":1700841223000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/advance-article\/doi\/10.1093\/biolre\/ioac141\/6644461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":101,"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioac141","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"article-number":"ioac141"}}